You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

Details for Patent: 9,388,159


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,388,159 protect, and when does it expire?

Patent 9,388,159 protects ERLEADA and is included in one NDA.

This patent has eighty-two patent family members in nineteen countries.

Summary for Patent: 9,388,159
Title:Substituted diazaspiroalkanes as androgen receptor modulators
Abstract: This invention provides for compounds of the Formula II: ##STR00001## wherein A, B, Het, R.sub.1, R.sub.2 and R.sub.3 are as described herein. These compounds are androgen receptor modulators useful for the treatment of androgen receptor-associated conditions.
Inventor(s): Jung; Michael E. (Los Angeles, CA), Sawyers; Charles L. (New York, NY), Ouk; Samedy (Los Angeles, CA), Tran; Chris (New York, NY), Wongvipat; John (New York, NY)
Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (Oakland, CA)
Application Number:14/318,234
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,388,159
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound; Delivery; Dosage form;

Drugs Protected by US Patent 9,388,159

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Janssen Biotech ERLEADA apalutamide TABLET;ORAL 210951-001 Feb 14, 2018 RX Yes No ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
Janssen Biotech ERLEADA apalutamide TABLET;ORAL 210951-002 Feb 17, 2023 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,388,159

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2368550 ⤷  Sign Up 300993 Netherlands ⤷  Sign Up
European Patent Office 2368550 ⤷  Sign Up CA 2019 00029 Denmark ⤷  Sign Up
European Patent Office 2368550 ⤷  Sign Up 2019C/529 Belgium ⤷  Sign Up
European Patent Office 2368550 ⤷  Sign Up 122019000060 Germany ⤷  Sign Up
European Patent Office 2368550 ⤷  Sign Up LUC00123 Luxembourg ⤷  Sign Up
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.